A(-20)C polymorphism of the angiotensinogen gene and pro-10 years is assumed to range between 80% and 85% gression of IgA nephropathy. from apparent onset [1]. Familial clustering of IgAN and Background. The M235T polymorphism of the angioteninter-individual differences in the clinical course suggests sinogen gene (AGT) is associated with an increased risk of that genetic factors may contribute to the development primary hypertension, which may then lead to progressive renal and progression of this disease. disease. Recent studies showed that nucleotide substitution in the 5Ј upstream core promoter region of AGT affects the basal Previous studies provided definitive evidence that antranscription rate of the gene. giotensinogen gene (AGT) variants are important in the Methods. To evaluate the role of AGT polymorphisms in pathogenesis of cardiovascular diseases such as hyperthe progression of IgA nephropathy (IgAN), we analyzed the tension. Changes in the 5Ј upstream core promoter reassociation of A(-20)C and M235T polymorphisms with renal gion of AGT, which is essential for the transcription of prognosis in histologically-proven IgAN patients using the Kaplan-Meier method and Cox proportional hazards regresangiotensinogen mRNA, may cause functional differsion model. ences that may contribute to pathogenesis [2]. One muta-Results. The incidence of hypertension during the course tion in particular, an adenine-to-cytosine transition at was associated with T235, but not with C(-20). The renal sur-Key words: mesangial proliferative glomerulosclerosis, progressive renal disease, glomerulonephritis, hypertension, M235T.
nucleotide -20 of the 5Ј upstream core promoter region vival rate for 137 patients with creatinine clearance (C Cr ) of 70 [A(-20)C] has been shown to increase the basal promoter mL/min or greater at the time of renal biopsy, and follow-up time of two years or more was significantly lower in the patients activity of AGT by increasing the affinity of adenoviral with C(-20) (P ϭ 0.008). The Cox proportional hazards regresmajor late transcription factor (MLTF) to this region of sion model showed an increased hazard ratio (HR) for urinary the promoter [3] . protein (more than 2 g/day) of 28.3 (95% CI, 7.3 to 109.8; P Ͻ The existence of an association between AGT poly-0.001), hypertension at the time of renal biopsy of 4.6 (95% CI, 1.8 to 11.9; P ϭ 0.002), and C(-20) of 3.6 (95% CI, 1.5 to morphisms and the progression of IgA nephropathy is 8.7 ; P ϭ 0.004). a controversial issue. Pei et al showed that patients with Conclusion. This work provides evidence that the C (-20) the AGT 235MT and TT genotypes have a faster rate polymorphism of AGT, a subset of T235 alleles, is associated of deterioration in creatinine clearance (C Cr ) than those with progression of renal dysfunction in IgAN. with the MM genotypes [4] . However, whether variations in the core promoter region of AGT are associated with an actuarial long-term renal prognosis in patients with Immunoglobulin A nephropathy (IgAN) is the most
IgAN is yet to be fully investigated. common glomerulonephritis among patients undergoing renal biopsy throughout the world. It is characterized by mesangial proliferative glomerulonephritis with pre-METHODS dominant IgA deposits. The actuarial renal survival at Patients
Patients were recruited from Niigata University Hospital (Niigata, Japan) as well as other hospitals in the IgAN was diagnosed by renal biopsy as a mesangial proliferative glomerulonephritis with predominant IgA  2002 by the International Society of Nephrology and C3 depositions in the mesangium. Henoch-Schö nlein These samples were separated by 3% agarose gel electrophoresis, and visualized by ethidium bromide staining. purpura and secondary IgAN as hepatic glomerulosclerosis were excluded from the analysis.
The M235T variant of AGT at exon two was determined as described previously [6] . To analyze the renal survival rate, 137 IgAN patients with a C Cr level of 70 mL/min or greater and a follow-Statistical analysis up time of two years or greater were studied. Patients whose C Cr value was less than 70 mL/min at the time of Pair-wise linkage disequilibrium (LD) coefficients were the renal biopsy were excluded because there may have estimated by the maximum-likelihood method and the been considerable differences in the onset of IgAN in extent of disequilibrium was expressed as DЈ ϭ D/D max these patients. Patients whose follow-up time was less or D/D min , according to Thompson et al [7] . Haplothan two years also were excluded in order to eliminate type frequencies for pairs of alleles were estimated using the influence of factors other than glomerulonephritis itthe Estimating Haplotype-Frequencies software program self. Clinical characteristics including age, sex, duration of (ftp://linkage.rockefeller.edu/software/eh). observation (in months), body mass index (BMI; kg/m 2 ), Statview 5.0J software (SAS Institute, Inc., Cary, NC, level of urinary protein excretion (g/day), serum creati-USA) was used for statistical analysis. Continuous varinine (S Cr ; mg/dL), and C Cr (mL/min) were investigated ables were expressed as mean Ϯ SD or percentage acin these patients. Hypertension was defined by the use cording to clinical features. When the baseline characterof one or more antihypertensive medications and/or a istic was continuous (age, disease duration, BMI, urinary blood pressure greater than or equal to 140 mm Hg systolic protein, S Cr , C Cr ), the unpaired t test and Mann-Whitney or 90 mm Hg diastolic blood pressure. The primary end U test were used. The 2 test was used when indicated. point was defined as the date at which S Cr levels doubled
The Kaplan-Meier method and the Cox proportional after the time of diagnosis, or when patients underwent hazards regression model analyzed the time course from their first hemodialysis. For statistical analysis, patients renal biopsy to the end point (initiation of dialysis or with C(-20) (N ϭ 55) were compared with those without when the S Cr level doubled after the time of diagnosis). C(-20) (N ϭ 82) for age, sex, BMI, blood pressure, pro-
In the Cox regression model, we tested covariates [age, teinuria, S Cr , C Cr at the time of renal biopsy, and medical sex, BMI, urinary protein, the category of hypertension, therapy.
steroid therapy, and administration of angiotensin-con-A similar analysis was performed in subgroups of the verting enzyme inhibitor (ACEI), and the gene polymorpatients with C Cr levels of 70 mL/min or greater who phism] by a stepwise backward method and several cowere followed for more than three (N ϭ 120) or five variates were selected. The effects of these covariates years (N ϭ 92).
were expressed by a hazard ratio. A P value less than 0.05 was considered statistically significant.
DNA analysis
Genomic DNA from each patient was prepared from RESULTS peripheral leukocytes in blood samples using an auto-
The genotype distribution in this study was not differmatic DNA isolation system (NA-100; Kurabo, Osaka, ent from that in Hardy-Weinberg equilibrium. The geno-Japan).
type and allele frequencies of AGT M235T and A(-20)C To determine the A-C transition at nucleotide -20 of did not differ from previously reported in Japanese studthe 5Ј upstream region of the core promoter of the AGT ies [5, [8] [9] [10] . Haplotype analysis showed a LD between gene, the following primers were constructed: 5Ј-primer, these two alleles (LD coefficient: DЈ, 1.00). Because the 5Ј-AGAGGTCCCAGCGTGAGTGTC-3Ј (nucleotides Ϫ166 to Ϫ144); 3Ј-primer, 5Ј-AGCCCACAGCTCAGT AGT variant at -20 was observed only in a subset of the 235T alleles, the following haplotypes were determined: TACATC-3Ј (nucleotides 81 to 101) [ (Table 1) . of 50 L containing 100 ng DNA, 10 pmol of each primer, 250 mmol/L of each of the four dNTPs, 1.5 mmol/L Clinical characteristics of the patients investigated are listed in Table 2 . A comparison between patients either MgCl 2 , 50 mmol/L KCl, 10 mmol Tris-HCl at pH 8.4, and 2 U of Taq polymerase (Takara, Shiga, Japan). The homozygous or heterozygous for C(-20) and those without C(-20) showed no significant differences in age, sex, PCR conditions were as follows: 30 cycles of 94ЊC for 30 seconds, 64ЊC for one minute, and 72ЊC for one mi-BMI, S Cr , C Cr , urinary protein excretion, blood pressure at the time of renal biopsy, or in the percentage of cases nute. After PCR, 265-bp products including the 5Ј upstream core promoter region were obtained. Then, 8.5 treated by ACEI. The percentages of patients administered an antihypertensive agent were not different be-L of the unpurified product was digested with 2 U of EcoO109I (Takara) for at least three hours at 37ЊC. tween the patients with C(-20) and those without C(-20). C(-20) (HR 4.6; 95% CI, 1.8 to 11.9; P ϭ 0.002).
DISCUSSION

Glucocorticoids were administered significantly more fre-
This study demonstrated that the renal survival rate quently in patients with C(-20) than those without C (-20) .
was significantly lower in patients with C(-20) in Japa-Because polymorphisms of AGT were reported to be nese patients with IgAN. The Cox proportional hazards associated with essential hypertension in a previous regression model showed an increased hazard ratio, 3.6 study, the frequencies of genotype M235T were comin multivariate analysis, indicating that this polymorpared between hypertensive and normotensive subjects phism is an independent risk factor for progression to at the time of renal biopsy and during the observation end-stage renal failure. period (Table 3) (-20) modynamic factors [14, 15] , cell proliferation and an in normotensive subjects was observed, which reflected increase in extracellular matrix [12, 16, 17] . In this study, the symmetrical decrease of T235 allele; however, no systemic hypertension may play a role in the decline of significant difference in the frequencies of the haplotype renal function in patients with AGT TT235, because the T235 & C(-20) between hypertensive and normotensive TT235 was significantly associated not only with hypersubjects was observed in both categories.
tension during the clinical course, but also with the renal To examine the effect of A(-20)C polymorphism on prognosis. These observations were assumed to reflect disease progression, we compared the survival rate from the influence of A(-6), which has been known to increase renal biopsy to the end point in those patients with C Cr the level of transcription of angiotensinogen, because level of 70 mL/min or greater at renal biopsy and a A(-6)G and M235T polymorphism of AGT are in comfollow-up time of two years or more. The renal survival plete LD [18, 19] . In contrast and unexpectedly, C(-20) rate in patients with C(-20) was significantly less ( 2 ϭ was significantly associated with renal prognosis inde-7.0, P ϭ 0.008) than in patients without C(-20) (Fig. 1) .
pendently of hypertension. Although the exact mecha-Moreover, in patients with a C Cr level of 70 mL/min or nism that explains these dissociated results on A(-20)C greater at renal biopsy and follow-up time of more than and M235T polymorphisms remained unclear, these rethree years (N ϭ 120; mean observed periods, 116.4 sults suggest that the transcriptional regulation of AGT months) or five years (N ϭ 92; mean observed periods, in the renal tissue is distinct from the systemic circulation. 137.5 months), the renal survival rate was significantly It has been reported that angiotensin II in renal interstitial lower in patients with C(-20) (P ϭ 0.02 at 3 years and fluids are much higher than plasma levels, suggesting the P ϭ 0.04 at 5 years). The renal survival rate in TT235 compartmentalization and independent regulation of renal patients (N ϭ 43) also was significantly lower than in angiotensin II [20] . Furthermore, recent haplotype studies MM/MT235 patients (N ϭ 94; P ϭ 0.02; Fig. 2) . demonstrated that LD between M235T and A(-20)C was not more complete than M235T and A(-6)G [18, 21] , The Cox proportional hazards regression model showed formation. However, the mean time to the end points HT at renal biopsy 0.002 4.6 1.8 to 11.9 in our study was nearly 10 years, and a substantial pro-AGT C(-20) 0.004 3.6 1.5 to 8.7 portion of the patients had stable or slowly declining Abbreviations are: U prot , urinary protein; HT, hypertension; HR, hazard ratio; CI, confidence interval. renal function during the follow-up period. D'Amico et al's study found that the speed of progression of endstage renal failure in IgAN patients was quite variable [25] . In fact, there was a large inter-individual difference although C(-20) is a subset of T235. There is a possibility in the time course to reach the end point, which was the that the A(-20)C polymorphism may be chiefly related to very point we investigated here as the genetic backthe local activation of renin-angiotensin system through ground. We employed a time-to-event analysis because a different transcriptional regulation, leading to renal it is suggested that, in a study including patients with dysfunction, whereas the M235T polymorphism may be stable renal function, an analysis of the time-to-event implicated with renal dysfunction through systemic hyapproach is favored over an analysis of mean slope of pertension. Further study is necessary to explore the renal function [26] . molecular mechanism of transcriptional regulation of Our study could not provide evidence that the AGT AGT in the kidney under both physiological and patho-C(-20) influenced the therapeutic effect of angiotensin logical conditions. II blockade by ACEI. In this respect, further investiga-Several earlier studies have analyzed an association tion with a long-term prospective observation of a large of T235 variants of AGT with the progression of IgAN. number of cases is necessary. However, our study sug-Pei et al showed that patients with MT and TT genotypes gests that genotyping of AGT at -20 and precise clinicohad a faster rate of deterioration of renal function than pathological assessments can lead to more accurate estithose with MM genotypes [4] . Because a large proportion mations of the prognosis, and to more proper and active of patients in their study were treated with antihypertenusage of ACEI or ARB in patients with IgAN. sive drugs (56 to 82%) and renal function in patients with MT or TT was moderately impaired, the effects of ACKNOWLEDGMENTS this polymorphism might be directly on blood pressure (6 to 7 years) appeared to be short for classifying the patients into categories. "Observation bias" would tend Reprint requests to Shin Goto, M.D., Division of Clinical Nephrology to misclassify the patients who may be destined to be in and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Niigata 951-8510, Japan.
